STEPHENSON BRIAN C
SEC CIK 1780030 · EDGAR
BoughtSold
Most active insiders at FTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| 2 | STEPHENSON BRIAN C | CFO | $1.13M | — |
| 3 | Peyer James | 10%, See remarks below | — | $787.8K |
| 4 | Cambrian BioPharma Inc | 10% | — | $787.8K |
| 5 | Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| 6 | Hahn Stephen M. | Dir | — | — |
Transactions 50
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-07-01 20:09 | 2026-06-29+ | FTH | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C | CFO | P - Purchase | $23.92 | +13.6K | 46.7K | +41% | +$326.1K |
| MI | 2026-06-26 19:40 | 2026-06-24+ | FTH | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C | CFO | P - Purchase | $25.65 | +15.6K | 33.1K | +90% | +$401.3K |
| MI | 2026-06-24 18:58 | 2026-06-22+ | FTH | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C | CFO | P - Purchase | $23.31 | +17.4K | 17.4K | New | +$405.9K |
| DMT | 2025-02-27 | 2025-02-25 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Treas | S - Sale+OE | $33.19 | -8,500 | 102.5K | -8% | -$282.1K |
| DT | 2025-02-27 | 2025-02-25 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Treas | M - OptEx | $17.00 | +8,500 | 111.0K | +8% | +$144.5K |
| DT | 2025-02-19 | 2025-02-19 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $36.16 | -4,148 | 102.5K | -4% | -$150.0K |
| DT | 2025-02-19 | 2025-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $34.90 | -13.1K | 106.6K | -11% | -$457.3K |
| DT | 2025-02-19 | 2025-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +25.8K | 119.7K | +27% | — |
| DT | 2025-01-30 | 2025-01-28 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $36.29 | -68.0K | 93.8K | -42% | -$2.47M |
| DT | 2025-01-30 | 2025-01-28 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | $17.00 | +68.0K | 161.8K | +73% | +$1.16M |
| T | 2024-11-20 | 2024-11-19 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $22.41 | -4,156 | 93.8K | -4% | -$93.1K |
| D | 2024-11-19 | 2024-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $23.72 | -13.1K | 97.9K | -12% | -$310.2K |
| D | 2024-11-19 | 2024-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +25.8K | 111.0K | +30% | — |
| DMT | 2024-08-20 | 2024-08-19 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $24.69 | -4,155 | 86.9K | -5% | -$102.6K |
| DT | 2024-08-20 | 2024-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $24.40 | -13.1K | 89.3K | -13% | -$319.1K |
| DT | 2024-08-20 | 2024-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +25.8K | 102.4K | +34% | — |
| D | 2024-05-17 | 2024-05-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $31.04 | -13.9K | 76.5K | -15% | -$432.8K |
| D | 2024-05-17 | 2024-05-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +27.5K | 90.4K | +44% | — |
| D | 2024-02-21 | 2024-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +45.0K | 81.8K | +122% | — |
| D | 2024-02-21 | 2024-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $37.21 | -18.9K | 62.9K | -23% | -$704.0K |
| D | 2023-11-20 | 2023-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +45.0K | 81.7K | +123% | — |
| D | 2023-11-20 | 2023-11-17 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $29.10 | -22.7K | 36.7K | -38% | -$660.1K |
| D | 2023-11-20 | 2023-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $28.86 | -22.3K | 59.4K | -27% | -$643.9K |
| D | 2023-08-18 | 2023-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $29.80 | -22.3K | 59.4K | -27% | -$664.9K |
| D | 2023-08-18 | 2023-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +45.0K | 81.7K | +123% | — |
| D | 2023-08-18 | 2023-08-17 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $28.59 | -22.7K | 36.7K | -38% | -$648.5K |
| D | 2023-05-18 | 2023-05-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +45.0K | 81.4K | +124% | — |
| D | 2023-05-18 | 2023-05-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $14.09 | -20.6K | 60.8K | -25% | -$289.9K |
| D | 2023-05-18 | 2023-05-17 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $14.01 | -24.4K | 36.4K | -40% | -$342.2K |
| 2023-05-05 | 2023-05-03 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $14.18 | -64.9K | 36.4K | -64% | -$920.7K | |
| 2023-04-07 | 2023-04-05 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $15.45 | -55.5K | 101.3K | -35% | -$857.5K | |
| 2023-03-03 | 2023-03-03 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $10.96 | -62.7K | 156.8K | -29% | -$687.1K | |
| D | 2023-02-21 | 2023-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +27.6K | 247.2K | +13% | — |
| DM | 2023-02-21 | 2023-02-17 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $12.70 | -17.7K | 221.7K | -7% | -$225.0K |
| D | 2023-02-21 | 2023-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $12.64 | -9,910 | 237.2K | -4% | -$125.3K |
| 2023-02-06 | 2023-02-03 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $11.01 | -61.0K | 219.2K | -22% | -$672.1K | |
| 2023-01-06 | 2023-01-05 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $7.67 | -61.0K | 280.2K | -18% | -$468.2K | |
| D | 2022-11-18 | 2022-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +30.5K | 371.7K | +9% | — |
| D | 2022-11-18 | 2022-11-17 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $9.40 | -19.7K | 341.3K | -5% | -$185.0K |
| D | 2022-11-18 | 2022-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $9.64 | -10.8K | 360.9K | -3% | -$104.0K |
| D | 2022-08-18 | 2022-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +26.7K | 350.5K | +8% | — |
| D | 2022-08-18 | 2022-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $11.08 | -9,227 | 341.3K | -3% | -$102.2K |
| D | 2022-05-18 | 2022-05-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | F - Tax | $6.74 | -9,228 | 323.8K | -3% | -$62.2K |
| D | 2022-05-18 | 2022-05-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | M - OptEx | — | +26.7K | 333.0K | +9% | — |
| D | 2022-02-18 | 2022-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | M - OptEx | — | +2,488 | 307.4K | +0.8% | — |
| D | 2022-02-18 | 2022-02-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | F - Tax | $8.84 | -1,020 | 306.4K | -0.3% | -$9,017 |
| D | 2021-11-18 | 2021-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | M - OptEx | — | +2,488 | 305.6K | +0.8% | — |
| D | 2021-11-18 | 2021-11-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | F - Tax | $47.25 | -1,234 | 304.4K | -0.4% | -$58.3K |
| D | 2021-08-18 | 2021-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | M - OptEx | — | +2,487 | 304.2K | +0.8% | — |
| D | 2021-08-18 | 2021-08-16 | BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | See Remarks | F - Tax | $49.48 | -1,028 | 303.1K | -0.3% | -$50.9K |
Purchase Sale Sale after option exercise All abbreviations